Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Haematologica|November 9, 2023
Autologous-allogeneic <i>versus</i> autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II studyNicolaus Kröger, Gerald Wulf, Ute Hegenbart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective StudyMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
American Journal of Hematology|November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMTAlicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.
Bone Marrow Transplantation|March 25, 2022
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMTRafal Machowicz, Felipe Suarez, Wieslaw Wiktor-Jedrzejczak, et al.
Journal of Clinical Medicine|June 24, 2022
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM StudyAnna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Nature Medicine|February 22, 2023
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantationBjörn-Erik Ole Jensen, Elena Knops, Leon Cords, et al.
Blood Cancer Journal|October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemiaChristina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Pageof 18